<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460360</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Comparative Efficacy of Parenteral and Mucosal Recombinant Probiotic Vaccines Against SARS-CoV-2 and <i>S. pneumoniae</i> Infections in Animal Models.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1195</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101195</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The accumulation of specific IgG antibodies in blood serum is considered a key criterion for the effectiveness of vaccination. For several vaccine-preventable infections, quantitative indicators of the humoral response have been established, which, when reached, provide a high probability of protection against infection. The presence of such a formal correlate of vaccine effectiveness is crucial, for example, in organizing preventive measures and validating newly developed vaccines. However, can effective protection against infection occur when the level of serum antibodies is lower than that provided by parenteral vaccination? Will protection be sufficient if the same vaccine antigen is administered via mucosal membranes without achieving high levels of specific IgG circulating in the blood?</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we compared the immunogenicity and protective efficacy of parenteral and mucosal forms of vaccines in experimental animals, targeting infections caused by the SARS-CoV-2 coronavirus and <i>Streptococcus pneumoniae</i>. We investigated the protective properties of a fragment of the coronavirus S1 protein administered intramuscularly with an adjuvant and orally as part of the probiotic strain <i>Enterococcus faecium</i> L3 in a Syrian hamster model. A comparative assessment of the immunogenicity and protective efficacy of a recombinant tandem (PSP) of immunogenic peptides from <i>S. pneumoniae</i> surface proteins, administered either parenterally or orally, was performed in a Balb/c mouse model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both models demonstrated significant differences in the immunogenicity of parenteral and oral vaccine antigens, but comparable protective efficacy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leontieva</LastName><ForeName>Galina</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9876-6594</Identifier><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramskaya</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupalova</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4824-3621</Identifier><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bormotova</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desheva</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9794-3520</Identifier><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korzhevsky</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Federal State Budgetary Science Institute "IEM", 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirik</LastName><ForeName>Olga</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-6113-3948</Identifier><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koroleva</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borisevitch</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Federal State Budgetary Institution 48th Central Research Institute of the Ministry of Defense of the Russian Federation, 141306 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suvorov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Scientific and Educational Center "Molecular Bases of Interaction of Microorganisms and Human" of the World-Class Research Center "Center for Personalized Medicine", Federal State Budgetary Scientific Institution «Institute of Experimental Medicine» (FSBSI «IEM»), 197376 Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>№075-15-2022-302(20.04.2022)</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mucosal vaccines</Keyword><Keyword MajorTopicYN="N">oral vaccination</Keyword><Keyword MajorTopicYN="N">parenteral vaccines</Keyword><Keyword MajorTopicYN="N">probiotic strain E. faecium L3</Keyword><Keyword MajorTopicYN="N">recombinant-probiotic-based vaccines</Keyword><Keyword MajorTopicYN="N">vaccine efficacy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460360</ArticleId><ArticleId IdType="pmc">PMC11512341</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101195</ArticleId><ArticleId IdType="pii">vaccines12101195</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Plotkin S.A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 2010;17:1055–1065. doi: 10.1128/CVI.00131-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00131-10</ArticleId><ArticleId IdType="pmc">PMC2897268</ArticleId><ArticleId IdType="pubmed">20463105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingson R.A., Figge F.H.J. A survey of the development of jet injection in parenteral therapy*. Anesth. Analg. 1952;31:361–366. doi: 10.1213/00000539-195211000-00073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-195211000-00073</ArticleId><ArticleId IdType="pubmed">13033448</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen L., Kane A., Lloyd J., Zaffran M., Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: A review. Bull. World Health Organ. 1999;77:789–800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2557743</ArticleId><ArticleId IdType="pubmed">10593026</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . State of the Worlds Vaccines and Immunizations. World Health Organization/United Nations Children’s Fund; Geneva, Switzerland: 1996. p. 159.</Citation></Reference><Reference><Citation>Bezredka A. Local Immunization. The Williams &amp; Wilkins Co.; Baltimore, MD, USA: 1927.</Citation></Reference><Reference><Citation>Dash P., Hakim A., Akter A., Al Banna H., Kaisar M.H., Aktar A., Jahan S.R., Ferdous J., Basher S.R., Kamruzzaman M., et al. Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants. mSphere. 2024;9:e0056523. doi: 10.1128/msphere.00565-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00565-23</ArticleId><ArticleId IdType="pmc">PMC10964428</ArticleId><ArticleId IdType="pubmed">38391226</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieye Y., Usai S., Clier F., Gruss A., Piard J.-C. Design of a protein-targeting system for lactic acid bacteria. J. Bacteriol. 2001;183:4157–41666. doi: 10.1128/JB.183.14.4157-4166.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.183.14.4157-4166.2001</ArticleId><ArticleId IdType="pmc">PMC95304</ArticleId><ArticleId IdType="pubmed">11418555</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., Aqib A.I., Fatima M., Muneer S., Zaheer T., Peng S., Ibrahim E.H., Li K. Deciphering the Potential of Probiotics in Vaccines. Vaccines. 2024;12:711. doi: 10.3390/vaccines12070711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12070711</ArticleId><ArticleId IdType="pmc">PMC11281421</ArticleId><ArticleId IdType="pubmed">39066349</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Singh M., Gaur S. Probiotics as multifaceted oral vaccines against colon cancer: A review. Front. Immunol. 2022;13:1002674. doi: 10.3389/fimmu.2022.1002674.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1002674</ArticleId><ArticleId IdType="pmc">PMC9573965</ArticleId><ArticleId IdType="pubmed">36263037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupalova T., Leontieva G., Kramskaya T., Grabovskaya K., Kuleshevich E., Suvorov A. Development of experimental pneumococcal vaccine for mucosal immunization. PLoS ONE. 2019;14:e0218679. doi: 10.1371/journal.pone.0218679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0218679</ArticleId><ArticleId IdType="pmc">PMC6599147</ArticleId><ArticleId IdType="pubmed">31251760</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvorov A., Gupalova T., Desheva Y., Kramskaya T., Bormotova E., Koroleva I., Kopteva O., Leontieva G. Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus. Front. Pharmacol. 2022;12:807256. doi: 10.3389/fphar.2021.807256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.807256</ArticleId><ArticleId IdType="pmc">PMC8823703</ArticleId><ArticleId IdType="pubmed">35145407</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvorov A., Loginova S., Leontieva G., Gupalova T., Desheva Y., Korzhevskii D., Kramskaya T., Bormotova E., Koroleva I., Kopteva O., et al. SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection. Vaccines. 2023;11:1714. doi: 10.3390/vaccines11111714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11111714</ArticleId><ArticleId IdType="pmc">PMC10675790</ArticleId><ArticleId IdType="pubmed">38006046</ArticleId></ArticleIdList></Reference><Reference><Citation>Desheva Y., Leontieva G., Kramskaya T., Gupalova T., Losev I., Kuleshevich E., Bormotova E., Kopteva O., Kudar P., Suvorov A. Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase. Microorganisms. 2021;9:2446. doi: 10.3390/microorganisms9122446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122446</ArticleId><ArticleId IdType="pmc">PMC8707194</ArticleId><ArticleId IdType="pubmed">34946050</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J. Neutralizing antibodies mediate virus-immune pathology of COVID-19. Med. Hypotheses. 2020;143:109884. doi: 10.1016/j.mehy.2020.109884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109884</ArticleId><ArticleId IdType="pmc">PMC7832094</ArticleId><ArticleId IdType="pubmed">32512289</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer A., Kehn-Hall K. Viral concentration determination through plaque assays: Using traditional and novel overlay systems. J. Vis. Exp. 2014:e52065. doi: 10.3791/52065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52065</ArticleId><ArticleId IdType="pmc">PMC4255882</ArticleId><ArticleId IdType="pubmed">25407402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengist H.M., Kombe A.J.K., Mekonnen D., Abebaw A., Getachew M., Jin T. Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity. Semin. Immunol. 2021;55:101533. doi: 10.1016/j.smim.2021.101533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2021.101533</ArticleId><ArticleId IdType="pmc">PMC8604694</ArticleId><ArticleId IdType="pubmed">34836774</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Mehl F., Zeichner S.L. Vaccine Strategies to Elicit Mucosal Immunity. Vaccines. 2024;12:191. doi: 10.3390/vaccines12020191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12020191</ArticleId><ArticleId IdType="pmc">PMC10892965</ArticleId><ArticleId IdType="pubmed">38400174</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Lam D.M.-K., Luan M., Zheng W., Ai H. Recent development of oral vaccines (Review) Exp. Ther. Med. 2024;27:223. doi: 10.3892/etm.2024.12511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2024.12511</ArticleId><ArticleId IdType="pmc">PMC11000446</ArticleId><ArticleId IdType="pubmed">38590568</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal Z., Ahmed S., Tabassum N., Bhattacharya R., Bose D. Role of probiotics in prevention and treatment of enteric infections: A comprehensive review. 3 Biotech. 2021;11:242. doi: 10.1007/s13205-021-02796-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-021-02796-7</ArticleId><ArticleId IdType="pmc">PMC8079594</ArticleId><ArticleId IdType="pubmed">33968585</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouelela M.E., Helmy Y.A. Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms. 2024;12:430. doi: 10.3390/microorganisms12030430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms12030430</ArticleId><ArticleId IdType="pmc">PMC10972033</ArticleId><ArticleId IdType="pubmed">38543481</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux A., Brosseau C., Bodinier M. Immunomodulation of B Lymphocytes by Prebiotics, Probiotics and Synbiotics: Application in Pathologies. Nutrients. 2023;15:269. doi: 10.3390/nu15020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15020269</ArticleId><ArticleId IdType="pmc">PMC9863037</ArticleId><ArticleId IdType="pubmed">36678140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotta C., Tognon M., Martini F., Torreggiani E., Rotondo J.C. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells. 2023;12:184. doi: 10.3390/cells12010184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12010184</ArticleId><ArticleId IdType="pmc">PMC9818925</ArticleId><ArticleId IdType="pubmed">36611977</ArticleId></ArticleIdList></Reference><Reference><Citation>Strumillo S.T., Kartavykh D., de Carvalho F.F., Cruz N.C., Teodoro A.C.d.S., Diaz R.S., Curcio M.F. Host–virus interaction and viral evasion. Cell Biol. Int. 2021;45:1124–1147. doi: 10.1002/cbin.11565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11565</ArticleId><ArticleId IdType="pmc">PMC8014853</ArticleId><ArticleId IdType="pubmed">33533523</ArticleId></ArticleIdList></Reference><Reference><Citation>Permar S.R., Klumpp S.A., Mansfield K.G., Kim W.-K., Gorgone D.A., Lifton M.A., Williams K.C., Schmitz J.E., Reimann K.A., Axthelm M.K., et al. Role of CD8+lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J. Virol. 2003;77:4396–4400. doi: 10.1128/JVI.77.7.4396-4400.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.7.4396-4400.2003</ArticleId><ArticleId IdType="pmc">PMC150640</ArticleId><ArticleId IdType="pubmed">12634396</ArticleId></ArticleIdList></Reference><Reference><Citation>Slamanig S., González-Domínguez I., Chang L.A., Lemus N., Lai T.Y., Martínez J.L., Singh G., Dolange V., Abdeljawad A., Kowdle S., et al. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice. EBioMedicine. 2024;105:105185. doi: 10.1016/j.ebiom.2024.105185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2024.105185</ArticleId><ArticleId IdType="pmc">PMC11200293</ArticleId><ArticleId IdType="pubmed">38848648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilfillan D., Vilander A.C., Pan M., Goh Y.J., O’flaherty S., Feng N., Fox B.E., Lang C., Greenberg H.B., Abdo Z., et al. Lactobacillus acidophilus Expressing Murine Rotavirus VP8 and Mucosal Adjuvants Induce Virus-Specific Immune Responses. Vaccines. 2023;11:1774. doi: 10.3390/vaccines11121774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121774</ArticleId><ArticleId IdType="pmc">PMC10747613</ArticleId><ArticleId IdType="pubmed">38140179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S. Live-Attenuated Bacterial Vectors for Delivery of Mucosal Vaccines, DNA Vaccines, and Cancer Immunotherapy. Pharm. Microbes. 2019;26:39–73. doi: 10.1007/978-3-030-01881-8_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-01881-8_2</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H., Zhao Z., Zhao Z., Chen Y., Zhang L. Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases. Int. J. Mol. Sci. 2022;23:594. doi: 10.3390/ijms23020594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020594</ArticleId><ArticleId IdType="pmc">PMC8775704</ArticleId><ArticleId IdType="pubmed">35054790</ArticleId></ArticleIdList></Reference><Reference><Citation>Holodick N.E., Rodríguez-Zhurbenko N., Hernández A.M. Defining natural antibodies. Front. Immunol. 2017;8:872. doi: 10.3389/fimmu.2017.00872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00872</ArticleId><ArticleId IdType="pmc">PMC5526850</ArticleId><ArticleId IdType="pubmed">28798747</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyneveld G.I., Savelkoul H.F.J., Parmentier H.K. Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review. Front. Immunol. 2020;11:2139. doi: 10.3389/fimmu.2020.02139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02139</ArticleId><ArticleId IdType="pmc">PMC7511776</ArticleId><ArticleId IdType="pubmed">33013904</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Lan C., Benlagha K., Camara N.O.S., Miller H., Kubo M., Heegaard S., Lee P., Yang L., Forsman H., et al. The interaction of innate immune and adaptive immune system. Medcomm. 2024;5:e714. doi: 10.1002/mco2.714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.714</ArticleId><ArticleId IdType="pmc">PMC11401974</ArticleId><ArticleId IdType="pubmed">39286776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Dong B.R., Hao Q. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev. 2022;2022:CD006895. doi: 10.1002/14651858.CD006895.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006895.pub4</ArticleId><ArticleId IdType="pmc">PMC9400717</ArticleId><ArticleId IdType="pubmed">36001877</ArticleId></ArticleIdList></Reference><Reference><Citation>Vera-Santander V.E., Hernández-Figueroa R.H., Jiménez-Munguía M.T., Mani-López E., López-Malo A. Health Benefits of Consuming Foods with Bacterial Probiotics, Postbiotics, and Their Metabolites: A Review. Molecules. 2023;28:1230. doi: 10.3390/molecules28031230.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28031230</ArticleId><ArticleId IdType="pmc">PMC9920731</ArticleId><ArticleId IdType="pubmed">36770898</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell R.A., Theisen R.M., Arnold K.B., Chung A.W., Selva K.J. Polyfunctional antibodies: A path towards precision vaccines for vulnerable populations. Front. Immunol. 2023;14:1183727. doi: 10.3389/fimmu.2023.1183727.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1183727</ArticleId><ArticleId IdType="pmc">PMC10433199</ArticleId><ArticleId IdType="pubmed">37600816</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunis J., Short K.R., Yu D. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation. Trends Microbiol. 2023;31:644–656. doi: 10.1016/j.tim.2022.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2022.12.008</ArticleId><ArticleId IdType="pmc">PMC9829516</ArticleId><ArticleId IdType="pubmed">36635162</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimzi M.A., Ham Y.-B. A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery. Pharmaceutics. 2021;13:1770. doi: 10.3390/pharmaceutics13111770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13111770</ArticleId><ArticleId IdType="pmc">PMC8620904</ArticleId><ArticleId IdType="pubmed">34834185</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathipa-Mdakane M.G., Thantsha M.S. Lacticaseibacillus rhamnosus: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control. Foods. 2022;11:785. doi: 10.3390/foods11060785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods11060785</ArticleId><ArticleId IdType="pmc">PMC8947445</ArticleId><ArticleId IdType="pubmed">35327208</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghihkhorasani A., Ahmed H.H., Mashool N.M., Alwan M., Assefi M., Adab A.H., Yasamineh S., Gholizadeh O., Baghani M. The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection. Virol. J. 2023;20:222. doi: 10.1186/s12985-023-02183-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02183-z</ArticleId><ArticleId IdType="pmc">PMC10548687</ArticleId><ArticleId IdType="pubmed">37789431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail B. The use of probiotics as vaccine vectors to prevent viral infections. In: Al Kassaa I., editor. New Insights on Antiviral Probiotics: From Research to Applications. Springer International Publishing; Cham, Switzerland: 2017. pp. 47–60.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>